The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.
Open accessAbstract
Intrinsic and acquired multidrug resistance (MDR) is an important problem in cancer therapy. MDR in human KB carcinoma cells selected for resistance to colchicine, vinblastine, or doxorubicin (former generic name adriamycin) is associated with overexpression of the "MDR1" gene, which encodes P-glycoprotein. We previously have isolated an overlapping set of cDNA clones for the human MDR1 gene from multidrug-resistant KB cells. Here we report the construction of a full-length cDNA for the human MDR1 gene and show that this reconstructed cDNA, when inserted into a retroviral expression vector containing the long terminal repeats of Moloney leukemia virus or Harvey sarcoma virus, functions in mouse NIH 3T3 and human KB cells to confer the complete multidrug-resistance phenotype. These results suggest that the human MDR1 gene may be used as a positive selectable marker to introduce genes into human cells and to transform human cells to multidrug resistance without introducing nonhuman antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., & Green, M. R. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7035 · Cited by 6,324
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Self-citationExpression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Self-citationGros, P., Croop, J., & Housman, D. (1986) · Cell · doi:10.1016/0092-8674(86)90594-5 · Cited by 1,031
Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines
Kartner, N., Riordan, J. R., & Ling, V. (1983) · Science · doi:10.1126/science.6137059 · Cited by 991
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Riordan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J., & Ling, V. (1985) · Nature · doi:10.1038/316817a0 · Cited by 826
Isolation and expression of a complementary DNA that confers multidrug resistance
Gros, P., Neriah, Y. B., Croop, J. M., & Housman, D. E. (1986) · Nature · doi:10.1038/323728a0 · Cited by 797
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4538 · Cited by 686
Self-citationGerlach, J. H., Endicott, J. A., Juranka, P. F., Henderson, G., Sarangi, F., Deuchars, K. L., & Ling, V. (1986) · Nature · doi:10.1038/324485a0 · Cited by 667
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1982) · PubMed · Cited by 659
Cited by
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Self-citationTargeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Self-citationThiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Self-citationMechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Self-citationBIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Self-citationSmit, J. J. M., Schinkel, A. H., Elferink, R. P. J. O., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van Roon, M. A., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90380-9 · Cited by 1,456
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance
Marzolini, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.012 · Cited by 895
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 882
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
“The multidrug resistance phenotype of the H69AR cells was somewhat similar to that previously, exclusively associated with the overexpression of P-gp/MDR1 (151, 219, 502).”
BackgroundResultThe multidrug transporter, a double-edged sword.
Gottesman, M. M., & Pastan, I. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37730-5 · Cited by 757
Self-citationNoonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7160 · Cited by 714
Multiple-Drug Resistance in Human Cancer
Flier, J. S., Underhill, L. H., Pastan, I., & Gottesman, M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162207 · Cited by 692
Self-citationMechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
Self-citationMechanisms of Drug Resistance in Cancer Chemotherapy
Luqmani, Y. A. (2005) · Medical Principles and Practice · doi:10.1159/000086183 · Cited by 651
Sarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A., & Scarborough, G. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42909-2 · Cited by 632
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
Phosphatidylcholine translocase: A physiological role for the mdr2 gene
Ruetz, S. (1994) · Cell · doi:10.1016/0092-8674(94)90446-4 · Cited by 599
Dumontet, C., & Sikic, B. I. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1061 · Cited by 574
Panwala, C. M., Jones, J. C., & Viney, J. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5733 · Cited by 567
The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research
Gottesman, M. M., & Ling, V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.060 · Cited by 558
Self-citationTaxanes, microtubules and chemoresistant breast cancer
McGrogan, B. T., Gilmartin, B., Carney, D. N., & McCann, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.10.004 · Cited by 535
Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V., & Willingham, M. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4486 · Cited by 484
Self-citationMicrotubules, microtubule-interfering agents and apoptosis
Mollinedo, F., & Gajate, C. (2003) · Apoptosis · doi:10.1023/a:1025513106330 · Cited by 477
ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.
Horio, M., Gottesman, M. M., & Pastan, I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3580 · Cited by 476
Self-citationA side order of stem cells: the SP phenotype
Challen, G. A., & Little, M. H. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0116 · Cited by 475
P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., & Ling, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252304 · Cited by 441
ABC transporters as mediators of drug resistance and contributors to cancer cell biology
Fletcher, J. I., Williams, R. T., Henderson, M. J., Norris, M. D., & Haber, M. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.03.001 · Cited by 423
Choi, K., Chen, C.-J., Kriegler, M., & Roninson, I. B. (1988) · Cell · doi:10.1016/0092-8674(88)90568-5 · Cited by 423
List, A. F., Kopecky, K. J., Willman, C. L., Head, D. R., Persons, D. L., Slovak, M. L., Dorr, R., Karanes, C., Hynes, H. E., Doroshow, J. H., et al. (2001) · Blood · doi:10.1182/blood.v98.12.3212 · Cited by 419
Devault, A., & Gros, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1652 · Cited by 418
Xiong, X.-B., & Lavasanifar, A. (2011) · ACS Nano · doi:10.1021/nn2013707 · Cited by 411
P-glycoprotein—A mediator of multidrug resistance in tumour cells
Germann, U. A. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00057-3 · Cited by 405
Cell biological mechanisms of multidrug resistance in tumors.
Simon, S. M., & Schindler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3497 · Cited by 369
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Biology of the multidrug resistance-associated protein, MRP
Loe, D. W., Deeley, R. G., & Cole, S. P. C. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00046-9 · Cited by 367
Drug interactions in cancer therapy
Scripture, C. D., & Figg, W. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1887 · Cited by 366
Strategies for reversing drug resistance
Fojo, T., & Bates, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206951 · Cited by 357
Smyth, M. J., Krasovskis, E., Sutton, V. R., & Johnstone, R. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7024 · Cited by 356
Functional involvement of P-glycoprotein in blood-brain barrier.
Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I., & Tsuruo, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88713-6 · Cited by 347
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Martino, E., Casamassima, G., Castiglione, S., Cellupica, E., Pantalone, S., Papagni, F., Rui, M., Siciliano, A. M., & Collina, S. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.06.044 · Cited by 337
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
GILLET, J., EFFERTH, T., & REMACLE, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 337
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
Fung, K. L., & Gottesman, M. M. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.02.014 · Cited by 335
Self-citationHamada, H., & Tsuruo, T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57324-0 · Cited by 332
Gill, D. R., Hyde, S. C., Higgins, C. F., Valverde, M. A., Mintenig, G. M., & Sepúlveda, F. V. (1992) · Cell · doi:10.1016/0092-8674(92)90263-c · Cited by 329
Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T., Morita, Y., Tamura, T., Aoyama, N., Hirai, M., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1012244520615 · Cited by 322
Modulation of multidrug-resistant multiple myeloma by cyclosporin
Sonneveld, P., Lowenberg, B., Durie, B. G. M., Lokhorst, H. M., Marie, J.-P., Zittoun, R., Solbu, G., Suciu, S., & Nooter, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)92353-h · Cited by 316
Johnstone, R. W., Cretney, E., & Smyth, M. J. (1999) · Blood · doi:10.1182/blood.v93.3.1075 · Cited by 315
Jasiński, M., Stukkens, Y., Degand, H., Purnelle, B., Marchand-Brynaert, J., & Boutry, M. (2001) · The Plant Cell · doi:10.1105/tpc.13.5.1095 · Cited by 311
Azzaria, M., Schurr, E., & Gros, P. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.12.5289 · Cited by 301
Hunter, J., & Hirst, B. H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00497-3 · Cited by 291
Sequence of mdr3 cDNA encoding a human P-glycoprotein
van der Bliek, A. M., Kooiman, P. M., Schneider, C., & Borst, P. (1988) · Gene · doi:10.1016/0378-1119(88)90057-1 · Cited by 289
Structure and expression of the human MDR (P-glycoprotein) gene family.
Chin, J. E., Soffir, R., Noonan, K. E., Choi, K., & Roninson, I. B. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3808 · Cited by 288
The Multixenobiotic Resistance Mechanism in Aquatic Organisms
Kurelec, B. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145320 · Cited by 287
Niel, E., & Scherrmann, J.-M. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.03.006 · Cited by 286
Ueda, K., Pastan, I., & Gottesman, M. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45397-5 · Cited by 286
Self-citationMultidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1.
van Veen, H. W., Venema, K., Bolhuis, H., Oussenko, I., Kok, J., Poolman, B., Driessen, A. J., & Konings, W. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10668 · Cited by 282
Van der Bliek, A. M., Baas, F., Ten Houte de Lange, T., Kooiman, P. M., Van der Velde-Koerts, T., & Borst, P. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02653.x · Cited by 281
Diestra, J. E., Scheffer, G. L., Català, I., Maliepaard, M., Schellens, J. H. M., Scheper, R. J., Germà‐Lluch, J. R., & Izquierdo, M. A. (2002) · The Journal of Pathology · doi:10.1002/path.1203 · Cited by 275
Expression of the Multidrug-Resistant Gene in Hepatocarcinogenesis and Regenerating Rat Liver
Thorgeirsson, S. S., Huber, B. E., Sorrell, S., Fojo, A., Pastan, I., & Gottesman, M. M. (1987) · Science · doi:10.1126/science.3576227 · Cited by 273
Self-citationRiganti, C., Miraglia, E., Viarisio, D., Costamagna, C., Pescarmona, G., Ghigo, D., & Bosia, A. (2005) · Cancer Research · doi:10.1158/0008-5472.516.65.2 · Cited by 271
Goh, B.-C., Lee, S.-C., Wang, L.-Z., Fan, L., Guo, J.-Y., Lamba, J., Schuetz, E., Lim, R., Lim, H.-L., Ong, A.-B., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.025 · Cited by 270
Shitan, N., Bazin, I., Dan, K., Obata, K., Kigawa, K., Ueda, K., Sato, F., Forestier, C., & Yazaki, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0134257100 · Cited by 268
Self-citationExploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Regulation of protein kinase C and role in cancer biology
Blobe, G. C., Obeid, L. M., & Hannun, Y. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00666107 · Cited by 255
MDR- and CYP3A4-mediated drug–herbal interactions
Pal, D., & Mitra, A. K. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.010 · Cited by 254
Genovese, I., Ilari, A., Assaraf, Y. G., Fazi, F., & Colotti, G. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.003 · Cited by 156
Gut bitter taste receptor signalling induces ABCB1 through a mechanism involving CCK
Jeon, T.-I., Seo, Y.-K., & Osborne, T. F. (2011) · Biochemical Journal · doi:10.1042/bj20110009 · Cited by 127
Structural insights into binding-site access and ligand recognition by human ABCB1
Kurre, D., Dang, P. X., Le, L. T. M., Gadkari, V. V., & Alam, A. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00361-z · Cited by 25
Wang, Y., Tu, M.-J., & Yu, A.-M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1423416 · Cited by 21
Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development
Hwang, G.-R., Yuen, J. G., & Ju, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041624 · Cited by 15
Metadata
- Authors
- Ueda, K., Cardarelli, C., Gottesman, M. M., & Pastan, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1987-05
- Volume
- 84
- Issue
- 9
- Pages
- 3004-3008
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2018652769
- Cited by
- 1,063
- References
- 28
- FWCI
- 17.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.